![Mark Forman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Forman
Hoofd Techniek/Wetenschap/O&O bij PASSAGE BIO, INC.
Vermogen: 55 439 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Mark Forman
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 27 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Forman via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin | |
Recludix Pharma, Inc.
![]() Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
SHIRE | Pharmaceuticals: Major | Public Communications Contact General Counsel | |
Scout Bio, Inc.
![]() Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chairman Founder | |
University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
VectivBio AG
![]() VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman Director/Board Member | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
University of Michigan | College/University | Masters Business Admin Doctorate Degree | |
DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
ARS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Quaker Partners Management LP
![]() Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Analyst | |
ZS Associates, Inc.
![]() ZS Associates, Inc. Miscellaneous Commercial ServicesCommercial Services ZS Associates, Inc. engages in the sales and marketing consulting, outsourcing, technology and software services. Its services include market segmentation, targeting, mergers, integration, forecasting and design. The company was founded by Prabhakant K. Sinha and Andy Zoltners in 1983 and is headquartered in Evanston, IL. | Miscellaneous Commercial Services | Consultant / Advisor | |
ARVINAS, INC. | Biotechnology | Director/Board Member | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
TELA BIO, INC. | Medical Specialties | Investor Relations Contact | |
AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Rallybio LLC
![]() Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Tufts University School of Medicine | College/University | Doctorate Degree | |
CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
NuMedii, Inc.
![]() NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Miscellaneous Commercial Services | Director/Board Member | |
TURG POIN | Pharmaceuticals: Major | Chief Executive Officer | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Capstan Therapeutics, Inc.
![]() Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chairman | |
Avenzo Therapeutics, Inc.
![]() Avenzo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Avenzo Therapeutics, Inc. is a biotechnology company that operates in the field of therapeutics. The company is based in San Diego, CA. The company was founded by Mohammad Hirmand and the CEO is Athena M. Countouriotis. | Miscellaneous Commercial Services | Chief Executive Officer | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member | |
Leal Therapeutics, Inc.
![]() Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Miscellaneous Commercial Services | Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Public Communications Contact | |
MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
SpringWorks Therapeutics LLC
![]() SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Chief Executive Officer | |
Disc Medicine Opco, Inc.
![]() Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Halda Therapeutics LLC
![]() Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Halda Therapeutics OpCo, Inc. | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 43 |
Zwitserland | 4 |
Ierland | 3 |
Verenigd Koninkrijk | 3 |
Frankrijk | 2 |
Sectoraal
Health Technology | 30 |
Consumer Services | 11 |
Commercial Services | 8 |
Finance | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 126 |
Corporate Officer/Principal | 61 |
Independent Dir/Board Member | 50 |
Chief Tech/Sci/R&D Officer | 33 |
Undergraduate Degree | 18 |
Sterkste connecties
Insiders | |
---|---|
Thomas Woiwode | 39 |
Tadataka Yamada | 36 |
Liam Ratcliffe | 32 |
Maxine Gowen | 23 |
Eliseo Salinas | 22 |
Sandipkumar S. Kapadia | 19 |
Athena Countouriotis | 17 |
Saqib Islam | 15 |
Michael Kamarck | 15 |
Derrell Porter | 14 |
Jill Quigley | 11 |
Bruce Goldsmith | 10 |
Alex Fotopoulos | 7 |
Desiree Luthman | 7 |
James M. Wilson | 6 |
- Beurs
- Insiders
- Mark Forman
- Bedrijfsconnecties